Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study.

BACKGROUND Physical activity in people with haemophilia (PWH) reduces the development of severe arthropathy, but it must be performed after regular, proper prophylaxis. Strict adherence to treatment is crucial to achieving effectiveness and established outcomes. The primary aim of this study was to collect prospective data on adherence to prophylaxis for over 36 months. A secondary aim was to verify whether adherence correlates with physical activity. MATERIALS AND METHODS Italian patients with severe haemophilia A treated on prophylaxis with octocog alfa were included in the study. Physical findings were assessed by the Haemophilia and Exercise Project (HEP)-Test-Q and the Early Prophylaxis Immunologic Challenge (EPIC)-Norfolk Physical Activity Questionnaire; orthopaedic status was assessed by the Hemophilia Joint Health Score (HJHS). Adherence was measured as percentage of empty vials returned with respect to the prescribed amount. RESULTS Forty-two PWH were enrolled: 31% children, 21.4% adolescents, and 47.6% adults. Type, frequency and impact of physical activities differed among the three groups. The HEP-Test-Q showed the highest impairments in the domains "endurance" and "strength/co-ordination". Eight percent of patients were classified as adherent to prophylaxis. Among them, 50% had at least one bleeding episode in the year before enrolment; this percentage dropped during the three years of the study. While remaining stable in the "non-adherent" group, the HJHS score decreased in the "adherent" patients. The mean number of school/work days lost was lower in adherent patients (from 3.4±6.8 to 0.2±0.9) than in non-adherent ones. DISCUSSION PWH with better orthopaedic scores reported better physical performance. Adherence to long-term prophylaxis proved to be high and correlated with a reduction in bleeds, target joints, school/work days lost, and with a performance improvement in endurance sports activities over time.

[1]  A. Hess,et al.  Management. , 2020, Anesthesiology.

[2]  M. Franchini,et al.  Impact of Exercise/Sport on Well-being in Congenital Bleeding Disorders , 2018, Seminars in Thrombosis and Hemostasis.

[3]  C. Thornburg,et al.  Treatment adherence in hemophilia , 2017, Patient preference and adherence.

[4]  C. Djambas Khayat Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B , 2016, Journal of blood medicine.

[5]  M. Schuurmans,et al.  Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study , 2016, British journal of haematology.

[6]  M. Witkop,et al.  Predictors of non‐adherence to prescribed prophylactic clotting‐factor treatment regimens among adolescent and young adults with a bleeding disorder , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  V. Jiménez‐Yuste,et al.  Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  R. Furlan,et al.  Adherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient survey , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  M. Witkop,et al.  Better adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  S. Jackson,et al.  An objective method for assessing adherence to prophylaxis in adults with severe haemophilia , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  S. Pérez-Alenda,et al.  Secondary prophylaxis vs. on‐demand treatment to improve quality of life in severe adult haemophilia A patients: a prospective study in a single centre , 2014, Vox sanguinis.

[12]  L. Mantovani,et al.  A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) , 2011, Journal of thrombosis and haemostasis : JTH.

[13]  W. Kronenberger,et al.  VERITAS‐Pro: a new measure of adherence to prophylactic regimens in haemophilia , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[14]  M. Herbsleb,et al.  Development and validation of a new questionnaire for the assessment of subjective physical performance in adult patients with haemophilia – the HEP‐Test‐Q , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[15]  H. M. van den Berg,et al.  A survey of adherence to haemophilia therapy in six European countries: results and recommendations , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  P. Mannucci,et al.  Effects of secondary prophylaxis started in adolescent and adult haemophiliacs , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  R. Ljung,et al.  Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG) , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[18]  J. Rice,et al.  Quantifying adherence to treatment and its relationship to quality of life in a well‐characterized haemophilia population , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[20]  S. Donadel-Claeyssens Current co‐ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management) , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  J. G. van der Bom,et al.  Use of implantable venous access devices in children with severe hemophilia: benefits and burden. , 2004, Haematologica.

[22]  J. Astermark,et al.  Consensus perspectives on prophylactic therapy for haemophilia: summary statement , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  N. Day,et al.  Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. , 2002, International journal of epidemiology.

[24]  M. Manco‐Johnson,et al.  Barriers to compliance with prophylaxis therapy in haemophilia , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  M. Gilbert Prophylaxis: musculoskeletal evaluation. , 1993, Seminars in hematology.

[26]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[27]  Å. Ahlberg Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. , 1965, Acta orthopaedica Scandinavica. Supplementum.

[28]  Eric F. Gardner,et al.  Summary Statement , 1946 .